SRC

Blue Sky Uranium Announces a Positive New Preliminary Economic Assessment for the Ivana Uranium-Vanadium Deposit, Amarillo Grande Project, Argentina

Retrieved on: 
Thursday, February 22, 2024

The materials mined are unconsolidated gravels and sands and are free digging, therefore drilling and blasting will not be required.

Key Points: 
  • The materials mined are unconsolidated gravels and sands and are free digging, therefore drilling and blasting will not be required.
  • Waste materials not used in construction will be stockpiled outside of the footprint of the pit.
  • Waste will be managed in the external stockpiles until it is used as in-pit backfill or for reclamation activities.
  • An alkaline leach circuit (sodium carbonate and bicarbonate) will be used to dissolve uranium and vanadium from the leach feed minerals.

Canada to Boost Supply of Critical Minerals and Strengthen Value Chains With Investment in the Saskatchewan Research Council

Retrieved on: 
Thursday, February 15, 2024

That is why Canada is seizing this opportunity by making smart investments in critical minerals value chains to support the development and deployment of clean energy and technology.

Key Points: 
  • That is why Canada is seizing this opportunity by making smart investments in critical minerals value chains to support the development and deployment of clean energy and technology.
  • This will help increase the supply of battery metals that are needed for the development of a domestic electric vehicle value chain.
  • Further, once the project is complete, Canada will be able to produce these critical minerals at commercial scale — a Canadian first for rare earth element processing.
  • The Critical Minerals Research Development and Demonstration (CMRDD) program supports the development of Canadian critical minerals value chains.

Premier American Uranium Engages SRC Swiss Resource Capital Ag for European Marketing

Retrieved on: 
Wednesday, February 14, 2024

TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Premier American Uranium Inc. (“PUR” or “Premier American Uranium”) (TSXV: PUR) is pleased to announce it has engaged SRC Swiss Resource Capital AG (“SRC”), an independent entity, to provide digital, translation, news, and communications services in Europe (the “Services”).

Key Points: 
  • TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Premier American Uranium Inc. (“PUR” or “Premier American Uranium”) (TSXV: PUR) is pleased to announce it has engaged SRC Swiss Resource Capital AG (“SRC”), an independent entity, to provide digital, translation, news, and communications services in Europe (the “Services”).
  • Each Option entitles SRC to acquire one PUR common share at an exercise price of $2.61 per share for a period of five years.
  • SRC is at arm’s length to PUR and has no other relationship with PUR, except pursuant to the Agreement.
  • The Agreement and the grant of the Options thereunder are subject to the approval of the TSX Venture Exchange.

Olivut Resources Ltd. Exploration Update

Retrieved on: 
Monday, February 5, 2024

TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Olivut Resources Ltd. (“Olivut” or the “Company”) (TSXV:OLV), is pleased to provide an exploration update.

Key Points: 
  • TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Olivut Resources Ltd. (“Olivut” or the “Company”) (TSXV:OLV), is pleased to provide an exploration update.
  • Four pyrope garnets in in addition to numerous picroilmenites and chromites were identified by SRC in these samples.
  • There is no known historical detailed exploration work in the region.
  • Unless otherwise stated, all forward looking statements speak only as of the date of this press release and the Company does not undertake any obligation to update such statements except as required by law.

Cosa Resources Completes Acquisition of the Titan Uranium Project, Athabasca Basin, Saskatchewan

Retrieved on: 
Wednesday, January 31, 2024

Vancouver, British Columbia--(Newsfile Corp. - January 31, 2024) - Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to announce completion of the previously announced acquisition (the "Acquisition") of the Titan uranium Property in the Athabasca Basin, Saskatchewan ("Titan" or the "Property") from CanAlaska Uranium Ltd. (the "Vendor") pursuant to a property acquisition agreement dated January 12, 2024 (the "Purchase Agreement").

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - January 31, 2024) - Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to announce completion of the previously announced acquisition (the "Acquisition") of the Titan uranium Property in the Athabasca Basin, Saskatchewan ("Titan" or the "Property") from CanAlaska Uranium Ltd. (the "Vendor") pursuant to a property acquisition agreement dated January 12, 2024 (the "Purchase Agreement").
  • The consolidated Orion project now covers 22 kilometres of the Larocque Lake trend midway between two uranium occurrences on the Cigar Lake trend.
  • The expanded Orion Project (the "Project") comprises 11 claims totaling 18,332 hectares and lies within 31 kilometres of the Cigar Lake Uranium Mine.
  • The Project covers 22 kilometres of the Larocque Lake trend which hosts the Hurricane uranium deposit, the Larocque Lake uranium zone, and the Alligator Lake uranium zone (Figure 2).

Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

Retrieved on: 
Monday, January 8, 2024

The last two patients were enrolled into the third dosing cohort, to receive ONCT-534 at a dose of 160 mg taken orally each day.

Key Points: 
  • The last two patients were enrolled into the third dosing cohort, to receive ONCT-534 at a dose of 160 mg taken orally each day.
  • The study utilizes an adaptive Bayesian Optimal Interval (BOIN) design, under which the first two dosing cohorts treated one patient each at 40 mg ONCT-534 per day and 80 mg ONCT-534 per day, respectively.
  • The decision to proceed to dose level 3 was confirmed by the study’s Safety Review Committee (SRC).
  • “The ONCT-534-101 investigators are enthusiastic about this study, and we are excited about the enrollment and progress through the initial dosing levels.

Fusion Pharmaceuticals Announces Clinical Program and Manufacturing Updates

Retrieved on: 
Thursday, January 4, 2024

In February 2023, Fusion acquired an IND for the ongoing Phase 2 clinical trial (the TATCIST trial) evaluating FPI-2265 (225Ac-PSMA I&T).

Key Points: 
  • In February 2023, Fusion acquired an IND for the ongoing Phase 2 clinical trial (the TATCIST trial) evaluating FPI-2265 (225Ac-PSMA I&T).
  • Fusion announced today encouraging early findings from Cohort 2 in the ongoing FPI-1434 Phase 1 clinical trial.
  • Fusion reported today that it has completed validation of its state-of-the-art good manufacturing practice (GMP) manufacturing facility and produced the first clinical dose of a TAT.
  • We built Fusion on a foundation of end-to-end manufacturing expertise, including experience with global radiopharmaceutical logistics and distribution.

Appia Rare Earths & Uranium - A Year in Review

Retrieved on: 
Thursday, December 28, 2023

President's Letter to Stakeholders and Shareholders

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - December 28, 2023) - Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) (MUN: A0I0) (BER: A0I0) (the "Company" or "Appia") reviews successes and achievements over 2023.
  • SGS, with vast experience in precious metals, base metals, and critical minerals, including rare earths, was selected for their unparalleled expertise in metallurgy and process development.
  • Once this stage is complete, the separated rare earths can be converted into metal in a metal smelting unit.
  • We invite you to visit our newly designed website , corporate presentation , and fact sheet , to learn more about Appia Rare Earths & Uranium.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – SRC, CSTR, NWLI, ROVR

Retrieved on: 
Wednesday, December 27, 2023

Under the terms of the agreement, SRC shareholders will receive 0.762 shares of RIC per share they own.

Key Points: 
  • Under the terms of the agreement, SRC shareholders will receive 0.762 shares of RIC per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, CSTR shareholders will receive 1.155 shares of Old National per share they own.
  • Under the terms of the agreement, ROVR shareholders will receive $11.00 in cash pers share they own.

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – NWLI, CSTR, ROVR, SRC

Retrieved on: 
Thursday, December 14, 2023

Under the terms of the agreement, NWLI shareholders are expected to receive $500.00 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, NWLI shareholders are expected to receive $500.00 in cash per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, CSTR shareholders will receive 1.155 shares of Old National per share they own.
  • Under the terms of the agreement, SRC shareholders will receive 0.762 shares of RIC per share they own.